SAM
AGIO icon

Seelaus Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Seelaus Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,015
Closed -$647K – 277
2021
Q3 		$647K Buy
+14,015
New +$677K 0.38% 76

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Seelaus Asset Management's AGIO Position: Q4 2021 in Review

Seelaus Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2021, closing a stake of 14,015 shares — an estimated $647K sold.

Seelaus Asset Management first reported a position in AGIO in Q3 2021 and held it in 1 quarter. The position peaked at $647K in Q3 2021. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2021.

  • Seelaus Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Seelaus Asset Management sold 14,015 Agios Pharmaceuticals shares in Q4 2021, an estimated $647K.
  • Seelaus Asset Management first reported a position in Agios Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Seelaus Asset Management's Agios Pharmaceuticals position peaked at $647K in Q3 2021.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2021.

Based on Seelaus Asset Management's 13F filing for Q4 2021, filed 10 Jan 2022.